TK2D Natural History, Mitochondrial Mechanism, and Multidisciplinary Care

"TK2D Natural History, Mitochondrial Mechanism, and Multidisciplinary Care" moves from onset-based phenotypes to prognosis, biology, and the care team.

Dr. Hirano asks how long patients can expect to live after onset without treatment. Dr. Zolkipli-Cunningham says clear natural history data exist. The youngest patients, particularly those under age 2, have the poorest outcomes and substantially higher mortality. A 2018 study showed median survival of about one year after onset in infantile disease. A 2026 study found a median of 2.6 years from onset to death in patients with onset before age 12, versus up to two decades with onset after age 12.

Turning to mechanism, Dr. Zolkipli-Cunningham explains that the TK2 gene encodes thymidine kinase 2, an enzyme in the mitochondrial matrix that is essential to the pyrimidine nucleotide salvage pathway. It phosphorylates thymidine and deoxycytidine, which are ultimately converted to the triphosphates needed for mitochondrial DNA synthesis. When TK2 activity falls, the deoxynucleotide pool becomes imbalanced. Models show this causes mitochondrial DNA depletion or deletions, oxidative phosphorylation defects, and reduced ATP in energy-dependent tissue such as skeletal muscle.

Dr. Hirano then asks which specialists should be involved. She says patients must be identified quickly and often present to primary care, neurology, neuromuscular, or genetics offices. Because TK2D is mitochondrial, any organ system can be involved. She recommends cardiology with echocardiogram and EKG, and pulmonology to assess breathing and nocturnal hypoventilation, which may require BiPAP. Gastroenterology, therapy services, primary care, urology, and social work also contribute.

He asks how to intervene when dysphagia causes weight loss. She says clinicians must watch for aspiration pneumonia, use barium swallow assessments, and ensure adequate nutrition, since ATP comes from food. Some patients need a long-term G-tube, and families should share that decision. Dr. Hirano notes that respiratory failure and pneumonia are leading causes of mortality, and she cautions that bulbar symptoms are not always apparent.

In "TK2D Case 1: Severe Early-Onset Presentation in a Four-Year-Old," Dr. Hirano presents a four-year-old girl with progressive weakness and feeding difficulty, and the panel works through what makes the diagnosis.

This program was supported by an independent medical education grant from UCB. the content was developed independently by NeurologyLive and the faculty. UCB has no control over the speakers, content, discussion or conclusions presented.